Back to search
Prophylaxis of A/H3N2v Influenza
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Prophylaxis of A/H3N2v Influenza trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Prophylaxis of A/H3N2v Influenza trials you may qualify forThis study will evaluate the safety and immunogenicity of the H3N2v MN 2010/AA ca live attenuated influenza vaccine (H3N2v LAIV) in healthy children and adults,…
Evaluate the safety and immunogenicity of three dosage levels of swine influenza vaccine in children ages 3 to \<9 years, adolescents 9 to \<18 years, adults 18…